Consistent with this response to PD-1 blockade following ACT, immunohistochemical analysis of the primary tumor revealed high expression of PD-L1, with a tumor proportions score of 80%, which represents the proportion of tumor cells expressing PD-L1. This evidence concerns the gene PDCD1 and neoplasm.